CAR-T Therapy Effective in Youngest Kids With ALL
Analysis shows safety and outcomes equivalent to those reported in older children
Stay updated with breaking news from Niralin Shah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysis shows safety and outcomes equivalent to those reported in older children
Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy Apr 1 2021 Children and young adults who receive CAR T-cell therapy for the most common childhood cancer - acute lymphoblastic leukemia - suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds. Daniel "Trey" Lee is conducting pioneering clinical research in the battle against childhood cancer. Image Credit: UVA Health The research, with an average follow up of nearly five years, suggests that st...